Literature DB >> 22878424

Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.

Catherine A Blish1, R Scott McClelland, Barbra A Richardson, Walter Jaoko, Kishorchandra Mandaliya, Jared M Baeten, Julie Overbaugh.   

Abstract

In women, genital HIV-1 RNA levels predict the risk of HIV-1 transmission independent of plasma viral load. To better understand the factors that contribute to genital HIV-1 shedding, we evaluated the relationships between genital and plasma cytokine concentrations and HIV-1 RNA levels. Vaginal, but not plasma, levels of interferon gamma-induced protein 10 (IP-10) were significantly associated with vaginal viral load, independent of plasma viral load. Thus, efforts to decrease HIV-1 transmission must take into account the role of local inflammation, which is not necessarily reflected in plasma measurements.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22878424      PMCID: PMC3494808          DOI: 10.1097/QAI.0b013e31826c2edd

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  21 in total

1.  Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

Authors:  Susan M Graham; Sarah E Holte; Norbert M Peshu; Barbra A Richardson; Dana D Panteleeff; Walter G Jaoko; Jeckoniah O Ndinya-Achola; Kishorchandra N Mandaliya; Julie M Overbaugh; R Scott McClelland
Journal:  AIDS       Date:  2007-02-19       Impact factor: 4.177

2.  Validation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples.

Authors:  Dana DeVange Panteleeff; Sandra Emery; Barbra A Richardson; Christine Rousseau; Sarah Benki; Sharon Bodrug; Joan K Kreiss; Julie Overbaugh
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

4.  Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.

Authors:  J M Baeten; P M Nyange; B A Richardson; L Lavreys; B Chohan; H L Martin; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

5.  Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation.

Authors:  Khalil G Ghanem; Nina Shah; Robert S Klein; Kenneth H Mayer; Jack D Sobel; D L Warren; Denise J Jamieson; Ann C Duerr; Anne M Rompalo
Journal:  J Infect Dis       Date:  2004-12-28       Impact factor: 5.226

6.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.

Authors:  Lucy R Mukura; Mimi Ghosh; John V Fahey; Susan Cu-Uvin; Charles R Wira
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

8.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

Authors:  J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

9.  The effect of hormonal contraception on genital tract shedding of HIV-1.

Authors:  Chia C Wang; R Scott McClelland; Julie Overbaugh; Marie Reilly; Dana DeVange Panteleeff; Kishorchandra Mandaliya; Bhavna Chohan; Ludo Lavreys; Jeckoniah Ndinya-Achola; Joan K Kreiss
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

10.  Positive association between HIV RNA and IL-6 in the genital tract of Rwandan women.

Authors:  Gregory T Spear; M Reza Zariffard; Hua Y Chen; Joshua J Anzinger; Kathryn Anastos; John Rusine; John Gatabazi; Audrey L French; Mardge Cohen; Alan L Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2008-07       Impact factor: 2.205

View more
  26 in total

1.  Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue.

Authors:  Anna Gibbs; Taha Hirbod; Qingsheng Li; Karin Bohman; Terry B Ball; Francis A Plummer; Rupert Kaul; Joshua Kimani; Kristina Broliden; Annelie Tjernlund
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

2.  Characterization of the Genital Microenvironment of Female Rhesus Macaques Prior to and After SIV Infection.

Authors:  Whitney A Nichols; Leslie Birke; Jason Dufour; Nisha Loganantharaj; Gregory J Bagby; Steve Nelson; Patricia E Molina; Angela M Amedee
Journal:  Am J Reprod Immunol       Date:  2015-08-20       Impact factor: 3.886

3.  Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1.

Authors:  Betsy C Herold; Charlene S Dezzutti; Barbra A Richardson; Jeanne Marrazzo; Pedro M M Mesquita; Colleen Carpenter; Ashley Huber; Nicolette Louissaint; Mark A Marzinke; Sharon L Hillier; Craig W Hendrix
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

4.  Increased Cervical Human Immunodeficiency Virus (HIV) RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure Compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3.

Authors:  Sharon A Greene; Christine J McGrath; Dara A Lehman; Kara G Marson; T Tony Trinh; Nelly Yatich; Evans Nyongesa-Malava; Catherine Kiptinness; Barbra A Richardson; Grace C John-Stewart; Hugo De Vuyst; Samah R Sakr; Nelly R Mugo; Michael H Chung
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

5.  Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition.

Authors:  Dara A Lehman; Keshet Ronen; Catherine A Blish; Jared M Baeten; Zahra Jalalian-Lechak; Walter Jaoko; Kishorchandra Mandaliya; Barbra A Richardson; R Scott McClelland; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

6.  Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.

Authors:  Eshan U Patel; Allison R Kirkpatrick; Mary Kate Grabowski; Godfrey Kigozi; Ronald H Gray; Jessica L Prodger; Andrew D Redd; Fred Nalugoda; David Serwadda; Maria J Wawer; Thomas C Quinn; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

7.  Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples.

Authors:  Erin M Kahle; Michael Bolton; James P Hughes; Deborah Donnell; Connie Celum; Jairam R Lingappa; Allan Ronald; Craig R Cohen; Guy de Bruyn; Youyi Fong; Elly Katabira; M Juliana McElrath; Jared M Baeten
Journal:  J Infect Dis       Date:  2014-11-10       Impact factor: 5.226

8.  Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines.

Authors:  Erica Andersen-Nissen; Joanne T Chang; Katherine K Thomas; Devin Adams; Connie Celum; Jorge Sanchez; Robert W Coombs; M Juliana McElrath; Jared M Baeten
Journal:  Sex Transm Dis       Date:  2016-12       Impact factor: 2.830

9.  A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.

Authors:  Athena P Kourtis; Lisa Haddad; Jennifer Tang; Lameck Chinula; Stacey Hurst; Jeffrey Wiener; Sascha Ellington; Julie A E Nelson; Amanda Corbett; Kristina De Paris; Caroline C King; Mina Hosseinipour; Irving F Hoffman; Denise J Jamieson
Journal:  Contemp Clin Trials       Date:  2016-11-09       Impact factor: 2.226

10.  Plasma interferon-gamma-inducible protein 10 can be used to predict viral load in HIV-1-infected individuals.

Authors:  Clive M Gray; Heather A Hong; Katherine Young; David A Lewis; Dorothy Fallows; Claudia Manca; Gilla Kaplan
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.